{"title": "Use of Cool Water Packs To Prevent Freezing During Vaccine Transportation at the Country Level", "author": "Umit Kartoglu; Serge Ganivet; Stephane Guichard; Venkat Aiyer; Peter Bollen; Denis Maire; Birhan Altay", "url": "https://journal.pda.org/content/63/1/11", "hostname": "journal.pda.org", "description": "Objectives: To study the impact of the use of cool water packs (water packs refrigerated at 2 to 8 \u00b0C) on the cold life of vaccine transport boxes and the shelf life of the vaccines. Methods: Data loggers were used to measure the temperatures of vaccine shipments with cool water packs in laboratory studies and country evaluations. The temperature recordings were mathematically translated into reduction of vaccines shelf life, which are illustrated through degrees of color changes of Vaccine Vial Monitors. Findings: Laboratory studies at extreme ambient temperatures (43 \u00b0C) showed that, with the use of cool water packs, temperatures inside the cold box rise to around 20 \u00b0C within 48 h. When this exposure scenario was repeated four times, the impact of the temperature history on the different heat stability categories of vaccines varied between 2.4 and 36.0% shelf life loss. Oral polio vaccine was found to be the most affected vaccine. All other vaccines were affected with 2.4 to 10.4% life loss. Country assessments (real life situation with temperature variations between day and night) showed between 0.4% to 4.6% life loss when the boxes were exposed to ambient temperatures ranging from 11.7 to 39.8 \u00b0C over the 98 h 15 min test period. Conclusions: The use of cool water packs is found to be a legitimate and safe practice for vaccines other than oral polio vaccine, so that cool water packs can safely replace frozen icepacks without any serious consequences on the ability of vaccines to confer protection against disease.", "sitename": "PDA Journal of Pharmaceutical Science and Technology", "date": "2009-01-01", "cleaned_text": "Research ArticleRESEARCH Use of Cool Water Packs To Prevent Freezing During Vaccine Transportation at the Country Level Umit Kartoglu, PDA Journal of Pharmaceutical Science and Technology January 11-26; - Milstien J., - Kartoglu U., - Zaffran M. - 2. [](#xref-ref-2-1)World Health Organization. The effects of freezing on the appearance, potency, and toxicity of adsorbed and unadsorbed DTP vaccines. Weekly Epidemiological Record 1980, 55, 385- 392. - 3. [](#xref-ref-3-1) - 4. [](#xref-ref-4-1) - Dimayuga R., - Scheifele D., - Bell A. - 5. [](#xref-ref-5-1) - Dietz V., - Galazka A., - van Loon F., - Cochi S. - 6. [](#xref-ref-6-1) - Gold M. S., - Martin L., - Nayda C. L., - Kempe A. E. - 7. [](#xref-ref-7-1) - 8. [](#xref-ref-8-1) - 9. [](#xref-ref-9-1) - 10. [](#xref-ref-10-1) - Lugosi L., - Battersby A. - 11. [](#xref-ref-11-1) - Nelson C. M., - Wibisono H., - Purwanto H., - Manssur I., - Moniaga V., - Widjaya A. - 12. [](#xref-ref-12-1) - Hanjeet K., - Lye M. S., - Sinniah M., - Schnur A. - 13. [](#xref-ref-13-1) - 14. [](#xref-ref-14-1) - Jeremijenko A., - Kelly H., - Sibthorpe B., - Attewell R. - 15. [](#xref-ref-15-1) - Thakker Y., - Woods S. - 16. [](#xref-ref-16-1) - Wawryk A., - Mavromatis C., - Gold M. - 17. [](#xref-ref-17-1) - Bishai D. M., - Bhatt S., - Miller L. T., - Hayden G. F. - 18. [](#xref-ref-18-1) - 19. [](#xref-ref-19-1)World Health Organization. Guideline for establishing or improving primary and intermediate vaccine stores. WHO/V&B/02.34; p 47. - 20. [](#xref-ref-20-1)World Health Organization. Immunization in Practice. WHO/IVB/04.06. - 21. [](#xref-ref-21-1)World Health Organization. Product Information Sheets 2000 Edition. WHO/V&B/00.13. - 22. [](#xref-ref-22-1)Protection of more cold sensitive vaccines. TechNet21 e-Forum. [http://listes.ulaval.ca/listserv/archives/technet21e.html](http://listes.ulaval.ca/listserv/archives/technet21e.html)Post00391E (26 November 2001), Post00386E (23 October 2001), Post00400E (19 December 2001), Post00419E (30 January 2002), and Post00428E (19 February 2002). - 23. World Health Organization. PQS performance specification: Vaccine vial monitor. Specification reference WHO/PQS/E06/IN05.1). Issued on 30 November 2006 ( [http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e06_in05_1.pdf](http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e06_in05_1.pdf)). - 24. [](#xref-ref-24-1) - 25. [](#xref-ref-25-1) - Kartoglu U. [http://listes.ulaval.ca/listserv/archives/technet21e.html](http://listes.ulaval.ca/listserv/archives/technet21e.html)Post00502E (20 September 2002). - 26. [](#xref-ref-26-1)World Health Organization. Getting started with vaccine vial monitors. WHO/V&B/02.35. - 27. [](#xref-ref-27-1) - Babalioglu N., - Kartoglu U. - 28. [](#xref-ref-28-1)World Health Organization. Study protocol for temperature monitoring in the vaccine cold chain. WHO/IVB/05.01. - 29. [](#xref-ref-29-1)World Health Organization. WHO-UNICEF Effective Vaccine Store Management initiative\u2014Model quality plan, Module 2. WHO/IVB/04.18. - 30. [](#xref-ref-30-1) - Soepardi J. - 31. [](#xref-ref-31-1) - Ganivet S. - 32. [](#xref-ref-32-1)World Health Organization. PQS performance specification: Vaccine cold box. Specification reference WHO/PQS/E04/CB01.1). Issued on 8 December 2008 ( [http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_1.pdf](http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_1.pdf)). - 33. [](#xref-ref-33-1)World Health Organization. PQS independent type-testing protocol: Vaccine cold box. Product verification protocol WHO/PQS/E04/CB01.VP.1). Issued on 8 December 2008 ( [http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_vp1.pdf](http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_cb01_vp1.pdf)). - 34. [](#xref-ref-34-1)World Health Organization. PQS performance specification: Vaccine carrier. Specification reference WHO/PQS/E04/VC01.1). Issued on 8 December 2008 ( [http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_1.pdf](http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_1.pdf)). - 35. [](#xref-ref-35-1)World Health Organization. PQS independent type-testing protocol: Vaccine carrier. Product verification protocol WHO/PQS/E04/VC01.VP.1). Issued on 8 December 2008 ( [http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_vp1.pdf](http://www.who.int/entity/immunization_standards/vaccine_quality/who_pqs_e04_vc01_vp1.pdf)). In This Issue [PDA Journal of Pharmaceutical Science and Technology](/content/63/1) Vol. 63, Issue 1 January/February 2009 Use of Cool Water Packs To Prevent Freezing During Vaccine Transportation at the Country Level Umit Kartoglu, Journal of Pharmaceutical Science and Technology Jan 2009, 63 (1) 11-26; Jump to section Related Articles - No related articles found. Cited By... - No citing articles found. More in this TOC Section Similar Articles "}